Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Bl d d M T l tBlood and Marrow Transplant ICU Utilization Project
Stanford BMTStanford BMT
March 2017
Disclosures
I have nothing to disclose I have nothing to disclose.
Confidential – For Discussion Purposes Only 2
The Question is……Can we do this?Can we do this?
− just one more test, treatment, or research protocol to offer)
Should we do this? − based on patients wishes, values & goals
In serious Illness, medical care is often mismatched with the patient values
This mismatch can cause big problems and unnecessary costs
Confidential – For Discussion Purposes Only
This mismatch can cause big problems and unnecessary costs
3
Measure & Analyze the problem
Average BMT ICU LOS per Case
14 00
6 89
11.68
8.00
10.00
12.00
14.00Da
ys
4.19
6.89
4.84
0.00
2.00
4.00
6.00ICU
Upward trend in BMT ICU LOS in CY2006
0.00CY 2003 CY 2004 CY 2005 CY 2006
YearData Updated: 9/8/08Source: (CY's: BMT Admin)
Confidential – For Discussion Purposes Only 4
Upward trend in BMT ICU LOS in CY2006
Measure & Analyze the problem
% Total ICU Days to Total Inpatient Days
6 0%
3.3%
5.1%
3.1%3 0%
4.0%
5.0%
6.0%ce
nt
1.5%
0.0%
1.0%
2.0%
3.0%
Perc
Upward trend in % BMT ICU Days vs
0.0%CY 2003 CY 2004 CY 2005 CY 2006
YearData Updated: 9/8/08Source: (CY's: BMT Admin)
Confidential – For Discussion Purposes Only 5
Upward trend in % BMT ICU Days vs
Total BMT inpatient days in CY 2006
Defining the problem
A i t tili ti i iti l ith i d t d Appropriate resource utilization is critical with increased costs and scarcity of ICU Beds
Communication between medicals teams is often fragmented resulting in conflicting information to patients and families
Unclear communication makes it difficult for patients and families to make educated decisions
These factors can result in over utilization of the ICU for non-beneficial care
Confidential – For Discussion Purposes Only 6
Major Findings from Stanford Study
A d i f i d i ti b t iA desire for improved communication between caregivers, patients, and families
47% f f ili f lt th i d t di t 47% of families felt they received contradictory messages
23% felt they received conflicting recommendations
Confidential – For Discussion Purposes Only 7
Source: 1998 Stanford End of Life survey- Family Interviews.
Communication
Confidential – For Discussion Purposes Only 8
EOL Discussions & Prognosis : Physicians
Don’t have the time - 66%
Not sure the time is right - 60% (not ready for PC or Hospice discussion)
Not sure what to say - 46%
No formal training 68% ASPEN FACUTY DEVELOPMENT Sept 2016
Confidential – For Discussion Purposes Only 9
Difficult Discussions 71% f th ti MD k & 29% ti t/f il k 71% of the time MDs speak & 29% patient/family speaks
− The more the family speaks the higher they rate the meeting in meeting their needs
Need to: Need to:
−Listen & Listen more
Answer questions ft d t di tl th i ti−Answer questions – often we do not directly answer their questions
−Acknowledge & address emotions
−Address principles of Palliative care−Address principles of Palliative care-
such as patient preferences, explanations of options, surrogate decision making
we will offer comfort care & we will not abandon them
Confidential – For Discussion Purposes Only (White et al, 2010)10
Patient and Family Conferences
Th ti f b i li t d t iThe perception of being listened to is one of the greatest predictors of g pPatient and Family satisfaction
Confidential – For Discussion Purposes Only 11
Project goals and benefits
PROJECT GOALS
Develop criteria to help determine when ICU admission and reevaluation is necessary
Decrease average ICU LOS without negatively impacting mortality
Decrease number of patients admitted to ICU when “No Stay Recommended” Decrease number of patients admitted to ICU when No Stay Recommended
Consistent evidence-based guidelines and tools for appropriate admission of BMT patients into ICU
PROJECT
Clarity of information and communication to patients and families enabling them to make educated decisions regarding care options
Improved patient, family and staff satisfaction
BENEFITS Appropriate utilization of ICU beds for BMT patients, thereby improving ICU throughput
Appropriate Resource utilization and deceasing costs
Avoid treating futile conditions that can result in unnecessary treatments
Confidential – For Discussion Purposes Only 12
Avoid treating futile conditions that can result in unnecessary treatments and sometimes painful procedures and deaths
BMT ICU Clinical Admission Guidelines Intensive BMT Care Recommended Intensive BMT Care Recommended
− Veno-occlusive Disease (VOD)/Sinusoidal Obstructive Syndrome(SOS)− Hypoxemia not requiring intubation especially if volume overload or transfusion related acute lung injury
(TRALI)− Sepsis without hypotension− Hypotension− Diffuse Alveolar Hemorrhage (DAH) − Cardiac Event− Airway Protection
Limited ICU Recommended – reevaluate within three days of ICU admission
− Severe Sepsis requiring intubation or vasopressors− Respiratory Failure requiring intubation
No ICU Recommended− Grade 4 Graft vs. Host Disease (GVHD) unresponsive to aggressive treatment with respiratory failure
R l d di if t t t t i t ti
Confidential – For Discussion Purposes Only 13
− Relapsed disease if recurrent treatment is not an option− Multi-organ Failure, requiring intubation (2 organs + mechanical ventilation)
Prognostication in BMT Patients Requiring ICU Care Counseling BMT pts with newer data needs to be predicated on Counseling BMT pts with newer data needs to be predicated on
probabilities from recent literature Probability of survival in pts mechanically ventilated ~15-30% Probability of survival in pts mechanically ventilated who require pressor
support is most commonly <10% and worsens with time Probability of survival in pts mechanically ventilated with hepatic and renal
f il i 5% d ith tifailure is <5% and worsens with time Pts and/or families should be told ahead of time and informed that re-
evaluation at 3-4 days will be important
Best references from 2003 onwards:− J Clin Oncol 24:643, 2006− Biol Blood Marrow Tx 12:301, 2006
Confidential – For Discussion Purposes Only 14
− Chest 126:1604, 2004− Crit Care Med 31:1715, 2003
H i di i d i Ri k & B fit f Having discussions around poor prognosis, Risks & Benefits of treatment options, probabilities of survival and making recommendations around EOL decisions are difficult for MDs.
In BMT, with our long length of stays & close relationships with our patients and families, it is even harder. pa e s a d a es, s e e a de
In BMT it is often a final treatment option for a terminal diagnosis
Discussions about futile treatment options can be difficult for some providers and are often initiated too late and only after patient deteriorate or go to the ICU
Confidential – For Discussion Purposes Only
deteriorate or go to the ICU
15
Prognosis: Patient Perspective
False hope is no hope
Often patients want to know
Absent explicit discussions, patients must infer
Information influences decisions
We would all live our lives differently if we knew we had only one year to live
Confidential – For Discussion Purposes Only 16
Process Improvement : for BMT Patients Admitted to ICU
BMT Team utilizes the BMT ICU Guidelines for managing appropriate ICU Admissions.ICU Admission
ICURounding
BMT and ICU Teams meet for daily rounds during the patient’s stay in the ICU.
ICUFamily
Conferences
BMT and ICU Teams meet with the patient or family every 2-3 days during ICU stay to update & clarify goals of care.
BMT Monitoring Tool utilized to monitor adherence to admission criteriaBMT Patient
Confidential – For Discussion Purposes Only 17
adherence to admission criteria. All ICU patients are reviewed monthly at the
BMT Review meeting.Review
Results
14 00
Average BMT ICU LOS per Case
11.68
9.61
8.00
10.00
12.00
14.00
ays
4.19
6.89
4.84
6.525.83
7.07
5.29
6.677.37
5.46
7.07
2.00
4.00
6.00
8.00
ICU
Da
0.00CY
2003CY
2004CY
2005CY
2006FY
2008FY
2009FY
2010FY
2011FY
2012FY
2013FY
2014FY
2015FY
2016YearData Updated: 2/20/17
Source: (CY's: BMT Admin) (FY 2008-2016: ICU Utilization Tool)
Confidential – For Discussion Purposes Only 18
Decrease in BMT ICU LOS
Results
BMT ICU Utilization ICU Day Comparison
290180
307435
191 FY 2016
FY 2015
FY 2014
FY 2013
292215
442210
0 100 200 300 400 500
FY 2012
FY 2011
FY 2010
FY 2009
BMT ICU DaysFY 2009
FY 2008
CY 2006Data Updated: 2/20/17Source: (CY 2006: BMT Admin) (FY 2008-2016: ICU Utilization Tool)
Confidential – For Discussion Purposes Only 19
Total BMT ICU Days per year
Results:BMT Project Utilization Impact: FY 2016
BMT Cases Transferred to ICU36 3634
40
BMT Cases Transferred to ICU
CY 2006
18
242121
36
16
24
19
36
2320
20
25
30
35
40
r of p
atie
nts
CY 2006
FY 2008
FY 2009
FY 201015
13
18
242121
11 11
15 16
24
19
2320
12
34
1215
20
25
30
35
Num
ber o
f pat
ient
s
CY 2006
FY 2008
FY 2009
FY 2010
FY 201115
9
1
13
2 1
11
2
11
3
15 16
3 30
12
3
0
5
10
15
Limited ICU Recommended ICU Recommended No ICU Recommended
Num
ber FY 2010
FY 2011
FY 2012
FY 2013
FY 2014
9
1 2 1
11
2
11
3 3 30
12
3
12
2
0
5
10
Limited ICU Recommended ICU Recommended No ICU Recommended
FY 2011
FY 2012
FY 2013
FY 2014
ICU Admission CriteriaFY 2015
FY 2016
Data Updated: 2/20/16Source: (CY 2006: Manual Chart Review) (FY 2008-2016: ICU Utilization Tool)
ICU Admission CriteriaFY 2015
FY 2016
Data Updated: 2/20/17Source: (CY 2006: Manual Chart Review) (FY 2008-2016: ICU Utilization Tool)
Confidential – For Discussion Purposes Only 20
More Patients that were recommended for the ICU went to the ICU
RESOURCES/COST SAVINGS 20 t f 410 ti t d itt d t th ICU h 20 out of 410 patients were admitted to the ICU who
did not meet the criteria in 9 years(1 was admitted t i ) Ab t 5%twice) About 5%.
−Total of 108 ICU days were associated with these y20 patients
−Mean ICU LOS was 4 4 days (shorter)−Mean ICU LOS was 4.4 days (shorter)
−Assuming average ICU charge of ~$50,000/day h 20 “N ICU” i $ 5 illi !
Confidential – For Discussion Purposes Only
those 20 “No ICU” patients cost over $ 5 million! 21
Decrease in % of ICU days to Inpatient BMT days
8 0%
% Total ICU Days to Total Inpatient Days
7 0%
% Total ICU Days to Total Inpatient Days
5.1%
7.1%
4.7%5.0%
6.0%
7.0%
8.0%
nt
5.9%
5.1%
4.5%
5.0%
6.0%
7.0%
t
1.5%
3.1%3.3% 3.5% 3.4% 3.4%
2.3%
4.1%
2.2%
3.4%
1.0%
2.0%
3.0%
4.0%
Perc
en
3.1% 3.1%
2.2%
3.4%
2.2%
2.7%
2.0%
3.0%
4.0%
Perc
ent
0.0%CY
2003CY
2004CY
2005CY
2006FY
2008FY
2009FY
2010FY
2011FY
2012FY
2013FY
2014FY
2015FY
2016YearData Updated: 2/20/16
Source: (CY's: BMT Admin) (FY 2008-2016: ICU Utilization Tool)
0.0%
1.0%
FY 2008 FY 2009 FY 2010 FY 2011 FY 2012 FY 2013 FY 2014 FY 2015 FY 2016
YearData Updated: 2/20/17Source: (CY's: BMT Admin) (FY 2008-2016: ICU Utilization Tool)
Confidential – For Discussion Purposes Only 22
( ) ( )
Stanford’s ICU Utilization Rate
I 2013 U it d H lth C ti (UHC)In 2013, United Healthcare Consortium (UHC) ICU utilization rate for HCT recipients was 29.6%
Stanford is ~ 5%
Confidential – For Discussion Purposes Only 23
Results
BMT ICU Discharge Disposition
25
40
25
35
24
29
40
24
30
25
30
35
40
45
f Pat
ient
s
FY 2008
9
4
17
6
11
2
16
610
5
17
5
16
58
00 05
10
15
20
5
Num
ber o
f FY 2008
FY 2009
FY 2010
FY 2011
FY 2012
FY 20130
D/C to E1 Deceased in ICU Deceased on E1
Disposition
FY 2013
FY 2014
FY 2015
FY 2016Data Updated: 2/20/17Source: ICU Utilization Tool)
Confidential – For Discussion Purposes Only 24
ICU BMT mortality rate decreased to 33%
ICU Mortality H it l t lit f ti t i i h i l til ti d Hospital mortality for patients requiring mechanical ventilation and
vasopressor support was 71%
Patients not requiring mechanical ventilation and vasopressor support was 24% (p< .0005).
A BMT comorbidity index (HCT-CI) was available for 71.3% of the patients.
−No significant difference between low index (0-3) score and high index (4-8) score
−Comorbidity did not effect ICU outcomes
Confidential – For Discussion Purposes Only
Comorbidity did not effect ICU outcomes
25
Strongest Predicter of Mortality Aft dj ti f ll i bl ( dAfter adjusting for all variables (age, gender, race,
product, preparative regimen, donor, GVHD, h i l til ti d/ )mechanical ventilation and/or vasopressor)
−Only 2 variables were significantly associated with y g ymortality
Age >55 yearsAge >55 years
Combination of mechanical ventilation with
Confidential – For Discussion Purposes Only
vasopressor support 26
Length of Stay (LOS)
Significant relationship between LOS and deathSignificant relationship between LOS and death.
−Patients with ICU LOS <5 days had a mortality of 33%
−Patients with ICU LOS >10 days had a mortality ofPatients with ICU LOS >10 days had a mortality of 74%
Confidential – For Discussion Purposes Only 27
Project Benefits
Appropriate admission of BMT patients into the ICU based on criteria from recent literature and probability of survival
Appropriate utilization of ICU beds for BMT patients which results in better resource utilization and avoiding futile, costly care
Consistent rounding between BMT and ICU facilitates communication among physicians, the care teams involved, and with the family
Consistent communication ensures accurate information to patients and families enabling them to make educated decisions regarding care
Increased satisfaction for patients families and staff
Confidential – For Discussion Purposes Only 28
Increased satisfaction for patients, families and staff
SummaryDATADATA
Clear Communication
−Critical for making informed decisions
−Essential for managing valuable resources
−and the appropriate Utilization of the ICU
Confidential – For Discussion Purposes Only 29
CURRENT /ONGOING PROJECTS
R t ti l f 400 d d ll ti t l t 7 t Retrospective eval of 400 deceased allo patients over last 7 years to evaluate presence or absence of AD and relationship of AD to ICU utilization, end of life healthcare utilization, and location of death
Retrospective eval of acute leukemia patients relapsing after allo to evaluate health care utilization at relapsee a ua e ea ca e u a o a e apse
Patient/Proxy study using Stanford Letter to determine if patient EOL wishes and caregiver’s perception of patients EOL wishes matchwishes and caregiver s perception of patients EOL wishes match.
randomized controlled trial of Stanford Letter vs standard AD in allotransplant patients
Confidential – For Discussion Purposes Only
transplant patients
30
BMT Physicians are using cutting edge technologies andBMT Physicians are using cutting edge technologies and clinical trials to advance the science of transplantation and improve cure rates creating a culture that can focus on the p gpotential for cure despite obvious suffering
Roland E et al, Journal of Supportive Oncology, May –June 2010: 8:100-116
Palliative care is best practice for patients with a serious illness to help relieve their symptoms and psychological distress.
It is recommended that Palliative Care be delivered with in the
Confidential – For Discussion Purposes Only
continuum of care for HCT patients
31
Collaborating with Palliative Care- future ideas
Consistent Palliative Care APP who rounds with BMT & develops relationship with both BMT team & patientswith both BMT team & patients
Requiring Advanced Directive (or Letter) for all BMT patient coming to Transplant.p
All High Risk BMT patient get an automatic referral to Palliative Care- need triggers
Others?
Confidential – For Discussion Purposes Only 32